Related Experiment Video
Updated: Apr 28, 2026

Author Spotlight: Exploring Orofacial Muscle Regeneration – Insights and Innovations
Published on: December 29, 2023
p53 and ATF4 mediate distinct and additive pathways to skeletal muscle atrophy during limb immobilization
Daniel K Fox1, Scott M Ebert1, Kale S Bongers1
1Departments of Internal Medicine and Molecular Physiology and Biophysics, Roy J. and Lucille A. Carver College of Medicine, University of Iowa, Iowa City, Iowa; and.
Abstract:
Immobilization causes skeletal muscle atrophy via complex signaling pathways that are not well understood. To better understand these pathways, we investigated the roles of p53 and ATF4, two transcription factors that mediate adaptations to a variety of cellular stresses. Using mouse models, we demonstrate that 3 days of muscle immobilization induces muscle atrophy and increases expression of p53 and ATF4. Furthermore, muscle fibers lacking p53 or ATF4 are partially resistant to immobilization-induced muscle atrophy, and forced expression of p53 or ATF4 induces muscle fiber atrophy in the absence of immobilization. Importantly, however, p53 and ATF4 do not require each other to promote atrophy, and coexpression of p53 and ATF4 induces more atrophy than either transcription factor alone. Moreover, muscle fibers lacking both p53 and ATF4 are more resistant to immobilization-induced atrophy than fibers lacking only p53 or ATF4. Interestingly, the independent and additive nature of the p53 and ATF4 pathways allows for combinatorial control of at least one downstream effector, p21. Using genome-wide mRNA expression arrays, we identified p21 mRNA as a skeletal muscle transcript that is highly induced in immobilized muscle via the combined actions of p53 and ATF4. Additionally, in mouse muscle, p21 induces atrophy in a manner that does not require immobilization, p53 or ATF4, and p21 is required for atrophy induced by immobilization, p53, and ATF4. Collectively, these results identify p53 and ATF4 as essential and complementary mediators of immobilization-induced muscle atrophy and discover p21 as a critical downstream effector of the p53 and ATF4 pathways.
Insights
Immobilization causes muscle atrophy through p53 and ATF4. These factors, along with p21, are key mediators of muscle wasting, with p21 being essential for atrophy.
Area of Science:
- Muscle physiology and molecular biology
- Cellular stress response pathways
- Skeletal muscle atrophy research
Background:
- Immobilization leads to skeletal muscle atrophy through poorly understood signaling pathways.
- Transcription factors p53 and ATF4 are involved in cellular stress adaptation.
Purpose of the Study:
- To investigate the roles of p53 and ATF4 in immobilization-induced skeletal muscle atrophy.
- To identify downstream effectors of p53 and ATF4 in muscle atrophy.
Main Methods:
- Utilized mouse models with muscle immobilization.
- Analyzed gene expression of p53, ATF4, and p21 in muscle fibers.
- Employed genome-wide mRNA expression arrays.
Main Results:
- Muscle immobilization increased p53 and ATF4 expression, causing atrophy.
- Muscle fibers lacking p53 or ATF4 showed partial resistance to atrophy.
- p53 and ATF4 acted independently and additively, with combined expression causing greater atrophy.
- p21 was identified as a critical downstream effector, essential for atrophy induced by immobilization, p53, and ATF4.
Conclusions:
- p53 and ATF4 are essential and complementary mediators of immobilization-induced muscle atrophy.
- p21 is a critical downstream effector of the p53 and ATF4 pathways in muscle atrophy.
- Understanding these pathways offers potential therapeutic targets for muscle wasting conditions.
More Related Videos
09:49Identification, Isolation, and Characterization of Fibro-Adipogenic Progenitors FAPs and Myogenic Progenitors MPs in Skeletal Muscle in the Rat
Published on: June 9, 2021
06:53Isolation and Differentiation of Primary Myoblasts from Mouse Skeletal Muscle Explants
Published on: October 15, 2019
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Satellite Stem Cells and Muscular Dystrophy